Selection of bispecific antibodies with optimal developability using FcRn-Ph-HPLC as an optimized FcRn affinity chromatography method

Müller, T; Tasser, C; Tesar, M; Fucek, I; Schniegler-Mattox, U; Koch, J; Ellwanger, K

Tasser, C (通讯作者)，Affimed GmbH, Discovery Res & Translat Immunol, Heidelberg, Germany.

MABS, 2023; 15 (1):

Abstract

A challenge when developing therapeutic antibodies is the identification of candidates with favorable pharmacokinetics (PK) early in development. A ke......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索